By consistently, we mean that a product should only be included if there are no negative decisions by any other well-known agency. Thus, if two or more agencies review a product, and any one of the agencies provides a negative review, the product is not considered to be consistently endorsed.

Note: Health Technology Assessment bodies such as the NICE in the UK, the IQWIG in Germany, the CDR in Canada and PBAC in Australia assess relative effectiveness and/or cost benefit of new medicines (depending on legislation), and provide recommendations on the benefit, use and/or reimbursement of medicines and interventions.